Flutemetamol
- 7 trials, none about aging, 3 with no results posted
Trials
0 about aging, of 7In trials
Phase 3Results posted6 trials
Phase 3Results posted4 trials
Phase 3Results posted1 trial
Phase 3Terminated1 trial
Phase 3Results posted1 trial
Phase 1Completed1 trial
Stopped
NCT01092546TerminatedAlzheimer's disease
Changed focus of the program
NCT02353949TerminatedAlzheimer's disease
Insufficient Recruitment
Trial sponsors
Company4 trialsPhase 3660 people
1 trialPhase 3448 people
1 trialPhase 311 people
1 trialPhase 112 people
Latest
23 in 12 monthsbioRxiv
Cognitive Fitness in Ageing (COFITAGE): A Multimodal and Longitudinal Neuroimaging Dataset
Preprint: cohort study of 101 peopleAI & data
Alzheimer's & Dementia
Regional amyloid accumulation, post-traumatic distress, and intrusive symptoms in cognitively unimpaired older adults at risk for Alzheimer's
Cohort study of 115 peopleMechanisms
Frontiers in Aging Neuroscience
Aging modulates amyloid clearance kinetics during anti-amyloid therapy: evidence from real-world serial amyloid PET
Cohort study of 23 peopleMechanisms
Annals of Nuclear Medicine
Regional distribution of an amyloid radiotracer in healthy aged human brain measured by PET with [¹⁸F]flutemetamol: a relation with myelin distribution
Cross-sectional study of 45 peopleBiomarkers
AAIC 2025 Abstract
Robustness of the Centiloid scale to target and reference regions calculated with a commercial software using [ ¹⁸ F]flutemetamol PET images
Cohort study of 80 peopleBiomarkers
AAIC 2025 Abstract
Interchangeability of Centiloid values from different research and commercial software using [ ¹⁸ F]flutemetamol PET images
Cohort study of 210 peopleBiomarkers